Selpercatinib New
Data Sheet
For research use only. Not for human use.
| Size | Price | Stock | Quotation Inquiry |
|---|---|---|---|
| 1.00 g | Get quote | In-stock | Quotation Inquiry |
| 2.00 g | Get quote | In-stock | Quotation Inquiry |
Get Quotation Now* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
| CAS No. | 2152628-33-4 | Cat. No. | BCP29047 |
| Name | Selpercatinib | ||
| Synonyms | LOXO-292;LOXO 292;LOXO292; | ||
| SMILES | CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O | ||
| Chemical Name | |||
| Formula | C29H31N7O3 | M. Wt | 525.25 |
| Purity | 98% | Storage | Store at 4-8°C |
| Description | Selpercatinib is an orally bioavailable selective inhibitor of wild-type, mutant and fusion products involving the proto-oncogene receptor tyrosine kinase rearranged during transfection (RET), with potential antineoplastic activity. Upon oral administration, selpercatinib selectively binds to and targets wild-type RET as well as various RET mutants and RET-containing fusion products. This results in an inhibition of cell growth of tumors cells that exhibit increased RET activity. In addition, selpercatinib targets, binds to and inhibits vascular endothelial growth factor receptor 1 (VEGFR1) and 3 (VEGFR3), and fibroblast growth factor receptor 1 (FGFR1), 2 (FGFR2), and 3 (FGFR3). RET overexpression, activating mutations, and fusions result in the upregulation and/or overactivation of RET tyrosine kinase activity in various cancer cell types; dysregulation of RET activity plays a key role in the development and progression of these cancers. | ||
Recommend Products
More >
-
-
-
-
-
Ret V804M-IN-1
Cat. No.：BCP37566
No.：2414909-94-5
Product Details -
cis-Pralsetinib
Cat. No.：BCP31224
No.：2097132-93-7
Product Details -
-
Pralsetinib
Cat. No.：BCP29411
No.：2097132-94-8
Product Details -
RET Kinase inhibitor 1
Cat. No.：BCP23560
No.：1627856-64-7
Product Details -
-
-
YN968D1 Hydrochloride
Cat. No.：BCP16050
No.：1218779-89-5
Product Details -
Regorafenib hydrochloride
Cat. No.：BCP09444
No.：835621-07-3
Product Details -
-
-
Regorafenib
Cat. No.：BCP02105
No.：755037-03-7
Product Details -
-
Regorafenib monohydrate
Cat. No.：BCP06668
No.：1019206-88-2
Product Details
Tags:Selpercatinib supplier,Selpercatinib purchase,Selpercatinib manufacturer,Selpercatinib distributor,Selpercatinib cost,Selpercatinib buy,Selpercatinib for sale